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Abstract
Background: Due to increasing numbers of people with diabetes taking part in extreme sports (e.g., high-altitude trekking),
reliable handheld blood glucose meters (BGMs) are necessary. Accurate blood glucose measurement under extreme
conditions is paramount for safe recreation at altitude. Prior studies reported bias in blood glucose measurements using
different BGMs at high altitude. We hypothesized that glucose-oxidase based BGMs are more influenced by the lower
atmospheric oxygen pressure at altitude than glucose dehydrogenase based BGMs.
Methodology/Principal Findings: Glucose measurements at simulated altitude of nine BGMs (six glucose dehydrogenase
and three glucose oxidase BGMs) were compared to glucose measurement on a similar BGM at sea level and to a laboratory
glucose reference method. Venous blood samples of four different glucose levels were used. Moreover, two glucose oxidase
and two glucose dehydrogenase based BGMs were evaluated at different altitudes on Mount Kilimanjaro. Accuracy criteria
were set at a bias ,15% from reference glucose (when .6.5 mmol/L) and ,1 mmol/L from reference glucose (when
,6.5 mmol/L). No significant difference was observed between measurements at simulated altitude and sea level for either
glucose oxidase based BGMs or glucose dehydrogenase based BGMs as a group phenomenon. Two GDH based BGMs did
not meet set performance criteria. Most BGMs are generally overestimating true glucose concentration at high altitude.
Conclusion: At simulated high altitude all tested BGMs, including glucose oxidase based BGMs, did not show influence of
low atmospheric oxygen pressure. All BGMs, except for two GDH based BGMs, performed within predefined criteria. At true
high altitude one GDH based BGM had best precision and accuracy.
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Introduction
Regular exercise and a healthy life style should be part of daily
life of everybody, but definitely of any person with diabetes
mellitus. Minimal requirements for exercise have been formulated,
with a minimum of 30 minutes of vigorous exercise or brisk
walking, five times weekly. However, increasing numbers of people
with diabetes do participate in more strenuous forms of physical
activity, amongst others high-altitude trekking and mountain
climbing. These kinds of activities do pose special challenges to
subjects with diabetes mellitus treated with insulin. Glucose levels
have to be kept under good control, and it is a challenge to find a
balance between energy intake, energy expenditure, blood glucose
levels, and insulin requirements. In general, frequent assessment of
blood glucose levels will be necessary to allow proper adjustments.
Therefore, both accuracy and easy accessibility of frequent
blood glucose measurements in subjects with type 1 diabetes
mellitus are paramount for a safe activity at high altitude.
Previous studies have examined the accuracy and reliability of
various glucose meters at (simulated) altitudes up to 5,000 m.
These and other studies with type 1 diabetes mellitus patients
indicated a considerable subset of the handheld blood glucose
meters (BGMs) to be unreliable at high altitude [1–6]. One could
hypothesize that glucose oxidase (GOX) BGMs, which use oxygen
as one of the substrates, would underestimate true glucose values
since less oxygen is available under hypobaric conditions. This
effect has been demonstrated by some [5]. Others have de-
monstrated oxygen independent BGMs using glucose dehydroge-
nase (GDH), to perform better under hypobaric conditions and
GOX based BGMs to underestimate true blood glucose levels [1].
However, these studies were limited by field- or simulated altitude
settings only [3–5], test protocols using only GOX based BGMs
[3], test protocols up to simulated altitudes ,4500 m [3–5] or with
outdated material [3,4].
Since we planned an expedition to climb Mount Kilimanjaro
with a team of people with type 1 diabetes mellitus, we were in
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The purpose of this study was to investigate whether modern
GDH or GOX based BGMs are reliable under simulated and true
high altitude conditions.
We hypothesized, that GDH based BGMs would be more
accurate than GOX based BGMs at high altitude, since GDH
based BGMs are by definition less oxygen dependent in their
reaction than GOX based BGMs.
Methods
Two experiments were performed; First, all BGMs were tested
at simulated altitudes in a hypobaric chamber. Second, a selection
of GOX and GDH based BGMs in the first experiment were used
during the ascent of Mount Kilimanjaro (5895 m).
The local ethics committee of the Isala Clinics Zwolle, the
Netherlands, approved the study protocol and all participants gave
written informed consent.
Hypobaric chamber experiment
We used a hypobaric chamber of the Dutch Airforce Research
facility in Soesterberg, The Netherlands. Six GDH and three
GOX based BGMs were tested at simulated altitudes: sea level,
2000 m, 3000 m, 4000 m and 5000 m while temperature (20uC)
and humidity were kept constant. GDH based BGMs used were;
Freestyle Mini and Precision X-ceed (both Abbott Diabetes Care,
USA), Hemocue 201+ (Quest Diagnostics U.K.), Accu-Chek
Aviva and Accu-Chek Compact Plus (both Roche Diagnostics,
Switzerland) and the Contour Link (Bayer, Germany). GOX
based BGMs used were; Glucocard Memory (Menarini Diagnos-
tics, Italy) Statstrip (Nova Biomedical, USA) and the Klinion
(Klinion Diabetes Care, Medeco the Netherlands) All BGMs used
were new - i.e. the same BGM was not extensively used for
medical practice before the experiments took place - to prevent
errors from wear and tear. Venous blood drawn from a healthy
individual spiked to a glucose concentration of 5, 10, 15 and
20 mmol/L was used as substrate to test BGMs. True glucose
values were determined with the laboratory certified Glucose
Hexokinase (GHex) based method (Roche Diagnostics, Manheim,
Germany). This GHex method is aligned with the GC-MS glucose
reference method. BGMs were simultaneously tested inside and
outside the hypobaric chamber, and samples were tested in
duplicate.
To prevent glucose variation due to time-dependent glycolysis
by cellular uptake in blood samples (5–7% per hour [7]) a blood
sample was prepared for GHex reference testing using a perchloric
acid preparation method. The latter was done at the time spiked
glucose samples were prepared – prior to BGM and GHex testing.
These blood samples were used for both GHex and BGM glucose
testing under normobaric and hypobaric conditions.
Field experiment
On Mount Kilimanjaro testing took place at incremental
altitudes (range 1300–4600 m), using capillary blood samples from
eight subjects with type 1 diabetes and eight healthy control
subjects. Care was taken to take a full droplet of blood from a
subject’s warm and clean index finger. Four BGMs, two GDH
based BGMs (Accu-Chek Compact Plus and Contour) and two
GOX based BGMs (Klinion and Glucocard) were used. Samples
were tested at temperatures ranging from 610–30uC using one
single sample of each subject. GHex reference testing was not
available at altitude. Instead, standard reference solutions (glucose
range 2.4–4.1; 4.4–6.7 and 14.0–17.9 mmol/L; NOVA biomed-
ical, USA) were used to test within-BGM performance at different
altitudes. These control solutions are made for the Statstrip BGM
and were primarily used to observe possible consistent biases
within that same BGM (precision) with repeated measures at
different altitudes. For between-BGM performance comparison
the best-tested BGM from the hypobaric chamber experiment –
the GDH based Accu-Chek Compact Plus- was used as a
reference. No air humidity was measured at altitude.
Analysis and statistics
Performance criteria for BGMs were set at a difference of
61 mmol/L of the reference method when ,6.5 mmol/L, or
615% when the reference sample read $6.5 mmol/L (Dutch
Organisation of Applied Physics and Science (‘‘TNO’’) guideline,
theNetherlands).Furthermore,Clarke’serrorgridanalysiswasused
to determine clinically relevant accuracy. [8] The error grid plots
the reference glucose and the glucose measured by the BGM on a x-
yplot.Thegrid isdividedinto5 zones(A–E)ofclinicalaccuracyand
corresponding treatment assumptions to correct the glucose value.
Zone A represents the target glucose range and glucose values are
clinically accurate; Zone B represents glucose values that deviate
.15% from the reference glucose leading to no or benign
treatment; Zone C glucose values would lead to overcorrection of
acceptable glucose values causing hyper- or hypoglycemia; Zone D
represents glucose values that could lead to dangerous misdetection
and failure to treat; Zone E glucose values are opposite from the
reference glucose leading to very dangerous treatment decisions.
Values in zone A and B are considered clinically acceptable.
Glucose measured by BGMs is presented in means (mmol/L) 6
SEMunlessstatedotherwise. Deviation ofmean BGMglucose from
the reference method is presented in percentage (%) and it’s range.
Overestimation is presented as the actual percentage and
underestimation is preceded by a minus (-) sign.
Results
Hypobaric chamber experiment
Each sample was tested in duplicate under hypobaric and
normobaric conditions simultaneously, and results are presented as
the mean glucose levels with absolute (mmol/L) or relative (%) bias
from GHex glucose determination.
Four of six tested GDH and all three GOX based BGMs
performed within predefined performance criteria of 61.0 mmol/
L when reference glucose was ,6.5 mmol/L and 615% when
reference glucose was .6.5 mmol/L at all simulated altitudes.
There were no mechanical failures due to hypobaric conditions.
One GDH based BGM (Freestyle mini) showed biases (range
15.2 to 18.5%) outside of predefined criteria for 7 out of 20 tested
glucose samples at simulated altitudes of 2000 m and 3000 m.
Also, this BGM showed biases outside of predefined criteria at 4
out of 20 sea level readings (range 16.0 to 18.5%).
Furthermore, another GDH based BGM (Precision X-ceed)
only showed biases outside of predefined criteria at sea level for 5,
10 and 15 mmol/L glucose samples (Table 1). In general, under
hypobaric conditions (at simulated altitude) both the GOX and
GDH based BGMs tended to overestimate glucose levels com-
pared to normobaric conditions (bias range; GDH BGMs: 28.2 to
16.9% and GOX BGMs: 0 to 10.8%) (Figure 1, 2 and Table 1, 2).
Table 1 and 2 demonstrate the relative bias (%) of the 10 mmol/L
test sample, and is representative for the remaining tested glucose
samples (5, 15 and 20 mmol/L).
As a group phenomenon, no significant difference was observed
between GOX- and GDH-BGMs under hypobaric conditions
(Bias at 2000–5000 m: 5.867.9 (25.0 to 19.1) vs. 7.566.5 (23.5
to 22.1) respectively (mean % 6 SEM (range %) (p=NS)).
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concentrations and were therefore not sample dependent.
Moreover, no trend in bias was seen for the individual BGMs
with increasing simulated altitude. However, one GDH-based
BGM performed better under hypobaric than under normobaric
conditions (Precision Xceed).
The best performing BGM under hypo- and normobaric
conditions and at all glucose concentrations tested was the GDH
based BGM Accu-chek Compact Plus. When further assessing the
specific results of the Accu-chek Compact Plus, there was a trend of
greater overestimation of 10 and 15 mmol/L glucose samples at
higher simulated altitudes. Furthermore, the smallest of biases was
found in the 20 mmol/L sample. However, the bias of this BGM
(bias range 21.1 to 6.7% at all glucose concentrations and
simulated altitudes) was well within predefined criteria for
acceptable bias and within meter variation was minimal. Moreover,
the meter was user-friendly, which is important, especially under
extreme conditions such as high altitude mountaineering.
Figure 1. Error grid analysis of 5, 10, 15 and 20 mmol/L glucose testing samples of BGMs (y- axis) against reference (GHex) (x-axis)
at sea level. Note: Leftward deviation from dashed line means overestimation of true glucose by tested BGM compared to GHex reference glucose
and vice versa. No differences were noted outside of predefined criteria due to testing conditions at sealevel (0 m) in and outside the hypobaric
chamber. Black diamonds = Contour; Black squares = Accu Chek Aviva; Black circles = Accuchek Compact Plus; Black triangles = Freestyle Mini;
Black asterixes = Precision; Black stripes = Hemocue; White squares = Klinion; White circles = Statstrip; White diamonds = Glucocard; Dashed line
= GHex reference glucose.
doi:10.1371/journal.pone.0015485.g001
Table 1. Relative bias (%) of GDH based BGMs compared to the Hexokinase laboratory reference method at different simulated
altitudes (10 mmol/L glucose sample).
GDH Hexokinase * Contour Link Accu-chek Aviva
Accu-chek
Compact Plus Freestyle Mini Precision Xceed Hemocue
Altitude
(m)
Glucose
(mmol/L)
normo
(%)
hypo
(%)
normo
(%)
hypo
(%)
no rmo
(%)
hypo
(%)
normo
(%)
hypo
(%)
normo
(%)
hypo
(%)
normo
(%)
hypo
(%)
0 10.05 3.8 4.3 3.8 1.5 2.9 1.5 2.4 15.5 11.1 9.5 22.6 20.5
2000 9.73 24.0 23.5 2.3 3.7 2.8 0.8 10.4 16.9 15.4 6.5 22.9 20.8
3000 9.38 22.5 2.8 0.8 23.0 2.8 2.8 12.8 15.2 15.9 8.1 26.5 23.0
4000 8.93 3.0 4.5 20.3 6.1 3.0 3.5 18.5 8.9 12.9 28.2 20.3 3.5
5000 8.50 6.1 0.0 6.1 5.0 4.5 4.5 17.1 11.5 12.8 0.6 2.9 7.6
Note: normobaric BGMs stay at sea level. (normo= bias under normobaric conditions (sea level); hypo= bias under hypobaric conditions (simulated altitude),
*= reference method).
doi:10.1371/journal.pone.0015485.t001
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Three standard glucose control solutions were used as a crude
reference method of BGM performance at Mt Kilimanjaro at
altitudes of 1300 m, 3000 m, 3700 m and 4600 m. Also one single
sample of capillary blood of eight subjects with type 1 diabetes
mellitus and eight healthy control subjects was used to test BGMs
at altitudes of 1300 m, 3000 m, 3770 m, 3900 m and 4600 m
altitude.
Measurements with the standard glucose control solutions
demonstrated consistent results of all BGMs except for the Klinion
GOX based BGM which showed a large within BGM variance at
different altitudes in all glucose ranges tested (Table 3). However,
when analyzing BGM accuracy in relation to the glucose solutions
reference measurements one GOX based BGM (Glucocard)
consistently underestimated true glucose measurement especially
in the lower glucose range (2.4 to 4.4 mmol/L). These results were
in accordance with results previously obtained in the hypobaric
chamber.
When comparing BGMs on Mount Kilimanjaro with the best
tested BGM in the hypobaric chamber (Accuchek Compact Plus; a
GDH based BGM) for capillary glucose samples of subjects with
type 1 diabetes mellitus and healthy controls at altitudes ranging
1300–4600 m, a total of 228 paired glucose measurements were
analyzed. Of these, 47 (21%) were outside of set performance
Figure 2. Error grid analysis of 5, 10, 15 and 20 mmol/L glucose testing samples of BGMs (y- axis) against reference (GHex) (x-axis)
at 5000 m simulated altitude. Note: Leftward deviation from dashed line means overestimation of true glucose by tested BGM compared to GHex
reference glucose and vice versa. Black diamonds = Contour; Black squares = Accu Chek Aviva; Black circles = Accuchek Compact Plus; Black
triangles = Freestyle Mini; Black asterixes = Precision; Black stripes = Hemocue; White squares = Klinion; White circles = Statstrip; White diamonds
= Glucocard; Dashed line = GHex reference glucose.
doi:10.1371/journal.pone.0015485.g002
Table 2. Relative bias (%) of GOX based BGMs compared to the Hexokinase laboratory reference method at different simulated
altitudes (10 mmol/L glucose sample).
GOX Hexokinase * Statstrip Klinion Glucocard
Altitude(m) Glucos(mmol/L) normo(%) hypo(%) normo(%) hypo(%) normo(%) hypo(%)
0 10.05 12.6 9.5 25.8 5.2 2.9 5.2
2000 9.73 14.7 10.8 27.5 0.8 3.7 3.7
3000 9.38 11.1 5.8 22.5 3.4 25.3 4.8
4000 8.93 4.5 6.1 20.8 0.8 3.5 6.1
5000 8.50 2.3 5.6 22.4 0.0 4.5 6.6
Note: normobaric BGMs stay at sea level. (normo= bias under normobaric conditions (sea level); hypo= bias under hypobaric conditions (simulated altitude),
*= reference method).
doi:10.1371/journal.pone.0015485.t002
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range, and specifically due to an overestimation (Fig 3). In
comparison to the reference BGM, the Glucocard, a GOX based
BGM, performed better than the Contour (GDH) and the Klinion
(GOX) BGMs (3 vs. 10 vs. 8% of bias outside performance criteria
respectively). Most BGM performance criteria violations were
observed at altitudes of 3000–3900 m.
Discussion
The present study was conducted to test accuracy and reliability
of GOX and GDH based BGMs at simulated and true high
altitude. We hypothesized that oxygen independent GDH based
BGMs would be more reliable and accurate at high altitude.
In contrast to previous reports and our hypothesis, no significant
differences were observed between GOX- and GDH-based BGMs
at simulated high altitude in all tested glucose ranges.
At true high altitude within-meter variation and accuracy
compared to standard reference glucose solutions was better in the
GDH based BGMs, and best in the Accu-Chek Compact Plus
BGM, independent from glucose solutions used.
In general, most BGMs tended to overestimate blood glucose at
high altitude.
At simulated high altitude one GDH based BGM performed
better under hypobaric conditions (Precision Xceed), possibly due
to in-meter failure of the normobaric BGM. This is suggested by
the fact that under normobaric conditions (sea level) this BGM
showed constant biases close to 15% in the 5, 10 and 15 mmol/L
glucose samples. Furthermore, the most inaccurate BGM in all
glucose ranges was the GDH based Freestyle Mini (28% of total
glucose readings . +15% bias) without an apparent effect of
altitude.
Lastly, there was a time dependent glucose lowering effect seen
in the reference samples (GHex) possibly due to cellular uptake
despite perchloric acid preparation of samples. (Table 1, 2) As
expected, a parallel decrement in glucose was observed when
testing all BGMs.
At true high altitude, the GOX based Glucocard BGM had
good within-meter variation and was reasonably accurate com-
pared to the reference BGM. However, when testing with
standard reference glucose solutions, it constantly showed
underestimation of the lowest glucose reference sample and was
at the low end of the other reference samples. This is not well
explained by chemical technique used as the other GOX based
BGM (Klinion) did not show this phenomenon. A possible
explanation might be that substances in the reference glucose
solution or errors in test strips interfered with glucose measure-
ment in this meter. [9]
Overestimation of glucose by BGMs at true altitude could have
dangerous consequences when hypoglycemia is falsely not shown
by BGM readings and hypoglycemic symptoms might not be fully
sensed due to extreme conditions. At the hyperglycemic range, the
therapeutic decisions made due to overestimation of true blood
glucose have less consequences than in the hypoglycemic range,
where not treating hypoglycemia could lead to life threatening
conditions. In this perspective, the findings of underestimation by
the Glucocard GOX based BGM in the low glycemic range are
not considered as dangerous as vice versa. On the contrary, if
overestimation of glucose by BGMs at simulated altitude is truly
present at true altitude this might lead to dangerous situations.
However, at simulated altitude overestimation was limited to 17
(9%) of all measurements, all of which fell in the lower B zone of
the error grid leading to no or benign treatment errors.
Research of BGMs at simulated high altitude up to 4000 m by
Gautier et al. has reported underestimation up to 228.9% using
venous blood samples of glucose ranges from 1.5 up to
26.3 mmol/L. However, this study did not differentiate between
GOX or GDH based BGMs and BGMs used are outdated today.
[4] Furthermore, O ¨ berg and O ¨ stenson tested four GDH and one
GOX based BGM at simulated and true high altitude up to 4500
and 5895 m respectively. Their study reported overestimation
ranging from 6.5 up to 15% of the GOX based BGM at normo-
and hyperglycemic glucose levels at 4500 and 2500 m. GDH
based BGMs performed better and overestimated true glucose
levels by 0.8 to 6.5% [1]. Interestingly, two similar GDH based
BGMs were used and bias observed did not correspond with our
study; the Contour (GDH based) BGM in their study showed an
underestimation (21.9 to 24.2%) and the Freestyle (GDH based)
BGM only showed a bias of +0.8% of both ,5.8 and
,16.5 mmol/L glucose samples. When GDH based BGMs were
Table 3. GOX and GDH based BGMs at Mount Kilimanjaro at different altitudes tested with standard glucose solutions.
Altitude Control solution GDH BGMs GOX BGMs
(m) Glucose (mmol/L) Glucose (mmol/L) Glucose (mmol/L)
Accu-chek Compact Plus Contour Klinion Glucocard
1300 2.4–4.1 3.9 2.7 4.6 1.9
4.4–6.7 5.6 5.5 6.0 4.7
14.0–17.9 14.7 15.7 17.5 14.7
3000 2.4–4.1 3.9 3.0 3.0 1.6
4.4–6.7 5.9 5.6 5.6 4.3
14.0–17.9 14.9 16.6 15.5 14.2
3700 2.4–4.1 3.9 2.5 3.2 1.8
4.4–6.7 5.4 5.7 5.9 4.4
14.0–17.9 14.5 15.5 16.4 13.8
4600 2.4–4.1 3.8 3.1 2.6 1.4
4.4–6.7 6.0 5.9 4.9 4.2
14.0–17.9 14.9 16.2 13.9 14.0
doi:10.1371/journal.pone.0015485.t003
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no reference method was used.
Our results differ from the findings in previous research. First,
we did not find a significant method-related difference between
GOX and GDH based BGMs at simulated high altitude. Second,
although not compared to a laboratory reference method, we did
not find a wide range of bias in GOX and GDH based BGMs up
to 4600 m at true high altitude.
A possible explanation for the first difference observed in
contrast to the study of Gautier et al. [4] might be improved
oxygen-based technique and sensitivity of the reagent for oxygen.
This is reflected by the fact that it takes less time to read out
glucose test strips results now than it took thirteen years ago,
suggesting that GOX based BGMs need less oxygen in order to
show a proper reaction.
In our study, BGMs were tested at simulated high altitude under
constant temperature and humidity, using a laboratory reference
method. Previous research reported low temperatures and
humidity influence accuracy of BGMs independent of altitude
[1–2]. This might have compromised field research at true high
altitude and explained the wide range of bias in cold conditions at
5895 m in the other studies. [1,2]. Since at 4600 m we tested
BGM’s at 28uC, the difference in temperature might explain this
contrasting result.
This study has limitations that might influence its results.
First, on Mount Kilimanjaro we could only test BGM’s on within
meter variation and relative bias compared to the best tested BGM,
but not on true biasdue to the lackof a laboratory reference method at
high altitude. Also, the reference solution used was not compared to a
laboratory reference method upon return from altitude. However,
BGMs showed consistent findings that were in good accordance with
results obtained with the hypobaric chamber experiment.
Second, on Mount Kilimanjaro blood glucose levels of tested
BGMs were compared to the best performing BGM as a reference
method based on results in a hypobaric chamber under constant
environmental conditions. One could speculate that alternating
temperatures and humidity on a mountain might influence the
accuracy of tested BGMs and the accuracy of the reference BGM
in particular, thereby compromising results. However, when
testing with standard glucose solutions, the reference BGM
showed best accuracy and within meter variation (Table 3).
Moreover, in our study we tested BGMs at temperatures ranging
from 10 to 28uC and these are well within the range of
temperatures stated by BGM manufacturers to provide reliable
glucose measurements.
Based on the tests in the hypobaric chamber and at true high
altitude we concluded that the Accu-check Compact Plus GDH
based BGM was most accurate at simulated altitude and most
precise at true high altitude.
Conclusion
No differences were observed between GDH and GOX based
BGMs at simulated altitude up to 5000 m. All of the tested BGMs,
Figure 3. Error grid analysis of glucose samples of all (healthy controls and diabetes type 1) subjects measured by GOX- and GDH-
BGMs (y-axis) at different altitudes on Mount Kilimanjaro (range 1300–4600 m) compared to Accuchek BGM glucose as a reference
method (x-axis); (mmol/L). Note: leftward deviation from dashed line indicates overestimation of glucose measured by BGM and rightward
deviation means underestimation by BGM compared to Accu-Chek BGM. Black diamonds = Contour; White squares = Klinion; White diamonds =
Glucocard; Dashed line = Accu Chek Compact Plus BGM as a reference glucose.
doi:10.1371/journal.pone.0015485.g003
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criteria for acceptable accuracy at simulated altitude. In general, at
simulated high altitude BGMs tend to overestimate true glucose
levels. At true high altitude GDH based BGMs performed better
in relation to within-meter variation and accuracy.
If a similar effect of overestimation is present at true high
altitude this could have dangerous consequences in the normo-
and hypoglycemic range. Therefore, true high altitude studies with
approved laboratory reference methods with measurement of
humidity and temperature as possible confounders are warranted.
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